Smart drug delivery platform based on cell-derived vesicles
Groundbreaking drug delivery platform that precisely delivers various drugs to targeted lesions by loading them into cell-derived vesicles (CDVs) derived from human cells.
MDimune is currently seeking partners for R&D collaborations that utilize the BioDrone™ (CDVs) platform for next-generation cell therapies or targeted payload delivery.
Flexible business model to collaborate with pharma/biotech partners in diverse therapeutic areas (cancer, rare diseases, CNS disorders, etc.).
Copyright © 2022 BioDrone Therapeutics Inc. - All Rights Reserved.